During the past decade, Cancer Hospital of Shantou University Medical College conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 3 clinical trials were completed, i.e. on average, 8.8% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 2 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Hospital of Shantou University Medical College" #1 sponsor was "BeiGene" with 9 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Chuangzhen Chen" with 5 trials sponsored, "Shanghai Junshi Bioscience Co., Ltd." with 2 trials sponsored and "Akeso" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Hospital of Shantou University Medical College" #1 collaborator was "Affiliated Cancer Hospital of Shantou University Medical College" with 1 trials as a collaborator, "Fudan University" with 1 trials as a collaborator, "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Shanghai Chest Hospital" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Hospital of Shantou University Medical College" are "Non-Small Cell Lung Cancer" (5 trials), "Cervical Cancer" (3 trials), "Esophageal Squamous Cell Carcinoma" (3 trials), "Breast Cancer" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Cancer Hospital of Shantou University Medical College" in a lesser frequency.

Most popular intervention types in "Cancer Hospital of Shantou University Medical College" are "Drug" (32 trials), "Biological" (4 trials), "Radiation" (4 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Paclitaxel" (6 trials), "Atezolizumab" (5 trials), "Cisplatin" (5 trials) and "Tislelizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Hospital of Shantou University Medical College" are 36 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are 29 active trials in "Cancer Hospital of Shantou University Medical College". 2 are not yet recruiting, 15 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Cancer Hospital of Shantou University Medical College, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Hospital of Shantou University Medical College, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".